Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Makoto Minamiyama
Observed names:
M. Minamiyama,
MAKOTO MINAMIYAMA,
Minamiyama, M.
Institution:
National Hospital Organization Suzuka National Hospital
Observed institutions:
National Hospital Organization,
National Hospital Organization Suzuka National Hospital,
Nagoya University
ORCID:
0000-0002-8159-7376
Observed ORCID:
0000-0002-8159-7376
OpenAlex ID:
A5031930678
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
2005
·
Masahiro Waza
, Hiroaki Adachi
, et al.
·
Nature Medicine
·
391
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy
2003
·
Masahisa Katsuno
, Hiroaki Adachi
, et al.
·
Nature Medicine
·
291
Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
2004
·
M. Minamiyama
·
Human Molecular Genetics
·
262
Heat Shock Protein 70 Chaperone Overexpression Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model by Reducing Nuclear-Localized Mutant Androgen Receptor Protein
2003
·
Hiroaki Adachi
, Masahisa Katsuno
, et al.
·
Journal of Neuroscience
·
258
PDF
Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease
2005
·
Masahisa Katsuno
, Chen Sang
, et al.
·
Proceedings of the National Academy of Sciences
·
236
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2
2012
·
Yu Miyazaki
, Hiroaki Adachi
, et al.
·
Nature Medicine
·
162
CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model
2007
·
Hiroaki Adachi
, Masahiro Waza
, et al.
·
Journal of Neuroscience
·
157
PDF
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy
2009
·
Haruhiko Banno
, Masahisa Katsuno
, et al.
·
Annals of Neurology
·
153
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse
2008
·
Keisuke Tokui
, Hiroaki Adachi
, et al.
·
Human Molecular Genetics
·
117
Reversible Disruption of Dynactin 1-Mediated Retrograde Axonal Transport in Polyglutamine-Induced Motor Neuron Degeneration
2006
·
Masahisa Katsuno
, Hiroaki Adachi
, et al.
·
Journal of Neuroscience
·
114
PDF
Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein
2006
·
Masahiro Waza
, Hiroaki Adachi
, et al.
·
Journal of Molecular Medicine
·
100
Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy
2010
·
Masahisa Katsuno
, Hiroaki Adachi
, et al.
·
Journal of Neuroscience
·
86
PDF
Heat shock proteins in neurodegenerative diseases: Pathogenic roles and therapeutic implications
2009
·
Hiroaki Adachi
, Masahisa Katsuno
, et al.
·
International Journal of Hyperthermia
·
75
PDF
Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration
2013
·
Naohide Kondo
, Masahisa Katsuno
, et al.
·
Nature Communications
·
61
PDF
p62/SQSTM1 Differentially Removes the Toxic Mutant Androgen Receptor via Autophagy and Inclusion Formation in a Spinal and Bulbar Muscular Atrophy Mouse Model
2013
·
Hideki Doi
, Hiroaki Adachi
, et al.
·
Journal of Neuroscience
·
59
PDF
Alleviating Neurodegeneration by an Anticancer Agent: An Hsp90 Inhibitor (17‐AAG)
2006
·
MASAHIRO WAZA
, HIROAKI ADACHI
, et al.
·
Annals of the New York Academy of Sciences
·
50
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract
2012
·
Makoto Minamiyama
, Masahisa Katsuno
, et al.
·
Nature Medicine
·
40
Genistein, a natural product derived from soybeans, ameliorates polyglutamine‐mediated motor neuron disease
2013
·
Qiang Qiang
, Hiroaki Adachi
, et al.
·
Journal of Neurochemistry
·
16
Cloning and characterization of the rat TIS11 gene
2000
·
Norio Kaneda
, Tomiyasu Murata
, et al.
·
Molecular and Cellular Biochemistry
·
8
Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability
2021
·
Seiya Noda
, Ayuka Murakami
, et al.
·
Internal Medicine
·
6
PDF
Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo‐optico‐neuropathy (SMON)
2021
·
Hideki Matsumoto
, Hideo Sasai
, et al.
·
Molecular Genetics & Genomic Medicine
·
5
Loss‐of‐function polymorphisms in NQO1 are not associated with the development of subacute myelo‐optico‐neuropathy
2024
·
Hideki Matsumoto
, Hideo Sasai
, et al.
·
Molecular Genetics & Genomic Medicine
·
2
PDF
Therapeutic strategies for spinal and bulbar muscular atrophy (SBMA)
2007
·
Katsuno, M.
, Banno, H.
, et al.
·
Drugs of the Future
·
1
2.31eP Evaluation of the efficacy of viltolarsen to Duchenne muscular dystrophy using muscular imaging
2026
·
Satoshi Kuru
, Makoto Minamiyama
, et al.
·
Neuromuscular Disorders
Preliminary Report on the Muscle Imaging Assessment of Viltolarsen Efficacy for Treating Duchenne Muscular Dystrophy
2026
·
Satoshi Kuru
, Makoto Minamiyama
, et al.
·
Neurology and Clinical Neuroscience
Show more works
View as search
Works count:
37
Citation count:
2,650
H-index:
17
I10-index:
18
Year
Topic
Type
